Business Wire

NY-JEFFERIES-FINANCIAL

28.5.2020 18:04:07 CEST | Business Wire | Press release

Share
Jefferies' Clients, Employees and Shareholders Contribute $9,250,000 to Over 85 Charities for Coronavirus Relief in Memory of Peg Broadbent

Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.

Through the firm’s Global Coronavirus Relief Charity Day held May 27th, Jefferies’ clients helped to generate $7.65 million in donated net trading commissions. In addition, Jefferies as a firm will donate $1 million directly, and voluntary donations from Jefferies’ 3,822 employees totaled $600,000.

“We could not be prouder of our entire Jefferies family for raising $9.25 million and are greatly appreciative of the incredible partnership our clients have shown us in supporting our fight against Covid-19. The full $9.25 million will be wired today and go to direct relief efforts at over 85 worthy global charities who are each in the front lines helping those most impacted by the Coronavirus global pandemic. We went broadly to a large number of charities globally as this is truly a tragedy that affects all of us and, in particular, those who are most disadvantaged and in the greatest need.

The charities selected are both big and small and represent everything from food banks, child care services, assistance with PPE and other medical supplies, support for front line medical workers, assistance for afflicted military personnel, local teen centers, support for police and fire, workforce training and re-training and many other worthy areas that are most in need. We thank our employees and clients for aiding in the selection of many of these remarkable charities.

Finally, all of us at Jefferies would like to thank all the dedicated professionals working tirelessly on the front line to help those in need. They are the true heroes whom we are honored to help in Peg’s name.”

Contributions in the following amounts will be immediately distributed to these respected organizations:

NYC Mayor’s Fund | Peg’s Cure

 

$ 150,000

All Hands and Hearts

 

$ 150,000

American Heart Association

$ 150,000

Bowery Mission

$ 150,000

Hackensack Meridian Health Foundation

$ 150,000

Houston Police Foundation

 

$ 150,000

International Rescue Committee

 

$ 150,000

Robin Hood Foundation

 

$ 150,000

Strive

 

$ 150,000

The Bass Foundation

 

$ 150,000

World Central Kitchen

 

$ 150,000

We Can #TogetherFromHome

 

$ 100,000

Achievement First

 

$ 100,000

Aktion Deutschland Hilft

 

$ 100,000

Alzheimer’s Association

 

$ 100,000

Ambitious About Autism

 

$ 100,000

Barnardo’s

$ 100,000

BMS Family Health and Wellness Center

 

$ 100,000

Bob Woodruff Foundation

 

$ 100,000

Boys & Girls Clubs of the Austin Area

 

$ 100,000

Brewers Community Foundation

 

$ 100,000

Buttle UK

 

$ 100,000

Central Texas Food Bank

 

$ 100,000

Chelsea and Westminster Hospital NHS Foundation Trust

 

$ 100,000

Chrysalis

$ 100,000

City Harvest

$ 100,000

Citymeals on Wheels

 

$ 100,000

Columbia Children's Hospital

 

$ 100,000

Community Food Bank of New Jersey

 

$ 100,000

Covenant House

 

$ 100,000

Doctors Without Borders

 

$ 100,000

East High – EOP (Education Partnership Organization)

 

$ 100,000

Elmhurst Hospital Charity

 

$ 100,000

Family Promise of Bergen County

 

$ 100,000

FarmLink

 

$ 100,000

Feeding America

 

$ 100,000

Food Bank For New York City

 

$ 100,000

Foodlink

 

$ 100,000

Habitat for Humanity Japan

 

$ 100,000

Hance Family Foundation

 

$ 100,000

Humanity & Inclusion

 

$ 100,000

Hunger Free America

 

$ 100,000

Imperial Health Charity

 

$ 100,000

Kids in Crisis

 

$ 100,000

Kohka Foundation

 

$ 100,000

Lahey Clinic Foundation

 

$ 100,000

Mail Force Charity

 

$ 100,000

Martha’s Table

 

$ 100,000

Médecins Sans Frontières

 

$ 100,000

Memorial Hermann Foundation

 

$ 100,000

My Sister's Place

 

$ 100,000

National Emergencies Trust

 

$ 100,000

Navajo Nation Covid-19 Relief Fund

 

$ 100,000

Nazareth Housing

 

$ 100,000

Neighbourly Community Fund

 

$ 100,000

NHS Charities Together

 

$ 100,000

Northwell Health's COVID-19 Emergency Fund

 

$ 100,000

NYU Langone

 

$ 100,000

Off Their Plate

 

$ 100,000

Oxfam India

 

$ 100,000

Philippine Disaster Resilience Foundation

 

$ 100,000

Red Hook Initiative

 

$ 100,000

Rosetree Trust

 

$ 100,000

Royal College of Nursing Foundation

 

$ 100,000

RVNAhealth

 

$ 100,000

Second Harvest

 

$ 100,000

Sempre Con Voi (Always with You)

 

$ 100,000

St Michael’s House

 

$ 100,000

TBD 1

 

$ 100,000

TBD 2

 

$ 100,000

TBD 3

 

$ 100,000

TCF Bank

 

$ 100,000

The Care Workers Charity

 

$ 100,000

The River Fund New York

 

$ 100,000

The United Way of Central Indiana COVID-19 Relief Fund

 

$ 100,000

The World Health Organization (WHO)

 

$ 100,000

Trinity's Services & Food for the Homeless

 

$ 100,000

The Trussell Trust

 

$ 100,000

UNICEF

 

$ 100,000

UR Medicine Home Care’s Meals on Wheels

 

$ 100,000

URMC COVID-19 Emergency Fund

 

$ 100,000

Valpo Surf Project, Inc.

 

$ 100,000

Volunteers of Legal Service

 

$ 100,000

Our Dream Their Smile

 

$ 100,000

West Side Campaign Against Hunger

 

$ 100,000

Women United in Philanthropy

 

$ 100,000

Women's Center of Greater Danbury

 

$ 100,000

 

 


$ 9,250,000

Jefferies Group LLC is the largest independent, global, full-service investment banking firm headquartered in the U.S. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. Jefferies Group LLC is a wholly owned subsidiary of Jefferies Financial Group Inc. (NYSE: JEF), a diversified financial services company.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release

AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys

Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A

Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release

Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye